首页DNA • NYSE
add
Ginkgo Bioworks Holdings Inc
昨日收盘价
$7.87
当日价格范围
$7.61 - $7.95
年度波幅
$5.00 - $45.20
市值
4.31亿 USD
平均交易量
142.14万
市盈率
-
股息率
-
主要交易所
NYSE
财务信息
损益表
收入
净收入
| (USD) | 2024年12月info | 年同比变化 |
|---|---|---|
收入 | 4384.70万 | 26.16% |
经营支出 | 1.28亿 | -29.52% |
净收入 | -1.08亿 | 49.20% |
净利润率 | -245.25 | 59.74% |
每股收益 | -1.21 | 58.78% |
息税折旧摊销前利润 | -7848.50万 | 44.39% |
有效税率 | 0.30% | — |
资产负债表
总资产
负债总额
| (USD) | 2024年12月info | 年同比变化 |
|---|---|---|
现金及短期投资 | 5.62亿 | -40.52% |
总资产 | 13.77亿 | -17.29% |
负债总额 | 6.61亿 | 16.40% |
权益总额 | 7.16亿 | — |
发行在外的股份 | 5436.58万 | — |
市净率 | 0.60 | — |
资产回报率 | -16.47% | — |
资本回报率 | -19.39% | — |
现金流
现金净变动
| (USD) | 2024年12月info | 年同比变化 |
|---|---|---|
净收入 | -1.08亿 | 49.20% |
来自运营的现金 | -4243.50万 | 26.62% |
投资现金 | -1308.50万 | 71.97% |
融资现金 | -20.30万 | 67.88% |
现金净变动 | -5579.60万 | 46.88% |
自由现金流 | -6446.84万 | -146.17% |
简介
Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT, headed by Jason Kelly. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It raised $290 million in September and $350 million in October of that year. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021. Wikipedia
CEO
成立时间
2008
员工数量
834
